1. Home
  2. FF vs NLSP Comparison

FF vs NLSP Comparison

Compare FF & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FF
  • NLSP
  • Stock Information
  • Founded
  • FF N/A
  • NLSP 2015
  • Country
  • FF United States
  • NLSP Switzerland
  • Employees
  • FF N/A
  • NLSP N/A
  • Industry
  • FF Major Chemicals
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FF Industrials
  • NLSP Health Care
  • Exchange
  • FF Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • FF 176.1M
  • NLSP 12.4M
  • IPO Year
  • FF N/A
  • NLSP 2021
  • Fundamental
  • Price
  • FF $4.04
  • NLSP $2.27
  • Analyst Decision
  • FF
  • NLSP
  • Analyst Count
  • FF 0
  • NLSP 0
  • Target Price
  • FF N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • FF 310.9K
  • NLSP 401.0K
  • Earning Date
  • FF 08-11-2025
  • NLSP 07-15-2025
  • Dividend Yield
  • FF 5.96%
  • NLSP N/A
  • EPS Growth
  • FF N/A
  • NLSP N/A
  • EPS
  • FF N/A
  • NLSP N/A
  • Revenue
  • FF $202,596,000.00
  • NLSP N/A
  • Revenue This Year
  • FF N/A
  • NLSP N/A
  • Revenue Next Year
  • FF N/A
  • NLSP N/A
  • P/E Ratio
  • FF N/A
  • NLSP N/A
  • Revenue Growth
  • FF N/A
  • NLSP N/A
  • 52 Week Low
  • FF $3.77
  • NLSP $1.30
  • 52 Week High
  • FF $6.40
  • NLSP $15.59
  • Technical
  • Relative Strength Index (RSI)
  • FF 49.74
  • NLSP 47.53
  • Support Level
  • FF $3.87
  • NLSP $2.16
  • Resistance Level
  • FF $4.41
  • NLSP $3.08
  • Average True Range (ATR)
  • FF 0.16
  • NLSP 0.24
  • MACD
  • FF 0.00
  • NLSP -0.03
  • Stochastic Oscillator
  • FF 33.04
  • NLSP 11.67

About FF FutureFuel Corp. Common shares

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: